New’revolutionary’ treatment for sickle cell illness reduces A&E visits by 40%.
SICKLE CELL DISEASE CAUSES RED BLOOD CELLS TO BE UNUSUALLY SHAPEED AND LAST LESS TIME THAN HEALTHY BLOOD CELLS.
A novel sickle cell medication has been approved, the first of its kind in 20 years, providing sufferers new hope for managing their disease. In addition, NHS England estimates that it will keep thousands of people out of hospitals over the next three years. Sickle cell disease has no cure at the moment, and it affects 15,000 people in the United Kingdom. People with an African or Caribbean ancestry are more likely to have it.
According to the BBC, the “revolutionary” medicine might cut the number of trips to A&E by up to 40%.
Crizanlizumab will be the first new medicine available for patients with the illness, according to the NHS.
It will be administered by a transfusion drip and works by attaching to a protein in blood cells to prevent blood and oxygen supply restrictions.
Over the following three years, it is envisaged that this will assist up to 5,000 people. People over the age of 16 who have had repeated sickle cell crises in the previous year will be eligible for the treatment.
Sickle cell disease is a term used to describe a set of genetic diseases that damage red blood cells. According to the NHS, the most dangerous kind is sickle cell anemia.
“Sickle cell disease is a serious and life-long illness, but treatment can help manage many of the symptoms,” it continues.
A gene that alters the development of red blood cells causes sickle cell disease.
According to the health organization, if both parents have the gene, each child they have has a one in four chance of being born with sickle cell disease.
NHS England established ten new specialist sickle cell disease treatment centers around the country last year, and patients will be able to obtain the new treatment through their consultant at one of these clinics.
“It is excellent news that this ground-breaking breakthrough treatment for sickle cell disease will soon be available in England, where it will make a difference to thousands of people’s lives,” Health and Social Care Secretary Sajid Javid said.
“The United Kingdom has established itself as a global leader in the deployment of novel, life-saving treatments to ensure that every NHS patient receives the best possible care,” according to Brinkwire Summary News.